| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artivion, Inc. (AORT) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AORT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 831.9K | $16.74M | - | |
| Other | 193.8K | $3.90M | - | |
| VP | 156.1K | $3.14M | - | |
| VP | 130.1K | $2.62M | - | |
| VP | 71.8K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | Horton Amy48 | VP, Chief Accounting Officer | Sell | 1,152 | $18.72 | $21,568.09 | -0.8% | +26.6% | +36.5% | |
| Feb 27, 2024 | Tyrs Florian | VP, Global Operations | Sell | 339 | $19.83 | $6,723.86 | -1.5% | +19.6% | +29.6% | |
| Feb 27, 2024 | Horton Amy48 | VP, Chief Accounting Officer | Sell | 325 | $19.83 | $6,446.18 | -0.2% | +19.6% | +29.6% | |
| Feb 27, 2024 | MacKin James P53 | President &CEO | Sell | 4,837 | $19.83 | $95,939.48 | -0.7% | +19.6% | +29.6% | |
| Feb 27, 2024 | Holloway Jean F49 | SVP, General Counsel | Sell | 485 | $19.83 | $9,619.68 | -0.3% | +19.6% | +29.6% | |
| Feb 27, 2024 | Davis John E | Chief Commercial Officer | Sell | 584 | $19.83 | $11,583.29 | -0.4% | +19.6% | +29.6% | |
| Feb 27, 2024 | Maney Rochelle L. | VP, Quality | Sell | 370 | $19.83 | $7,338.76 | -0.8% | +19.6% | +29.6% | |
| Feb 27, 2024 | Getz Matthew A | VP, Human Resources | Sell | 325 | $19.83 | $6,446.18 | -0.7% | +19.6% | +29.6% | |
| Feb 27, 2024 | Green Andrew M | VP Regulatory | Sell | 421 | $19.83 | $8,350.28 | -0.9% | +19.6% | +29.6% | |
| Feb 27, 2024 | Stanton Marshall S. | SVP, Clinical &MD Affair | Sell | 465 | $19.83 | $9,223.00 | -0.6% | +19.6% | +29.6% |